Personalis Inc (PSNL)
Healthcare
Diagnostics & Research
13.50 $
+2.4%
vs. previous close
Closing price · As of: 4. Aug 2026
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +9.3% | +7.8% | -0.8% | +15.6% | +13.9% | -34.7% | +22.6% | -16.5% | -15.7% | +19.7% | -10.8% | – | |
| – | +24.0% | -2.0% | -3.0% | +3.6% | +16.6% | -27.8% | +9.4% | -7.1% | +1.1% | +22.8% | -1.7% | – | |
| – | -27.4% | +49.5% | +5.5% | +46.3% | +8.8% | -48.0% | +58.4% | -34.0% | -59.8% | -0.7% | -85.2% | – | |
| – | -6.2% | -18.7% | -6.2% | +1.5% | -9.8% | -1.6% | +10.0% | -2.0% | -1.7% | +7.4% | +11.2% | – | |
| – | -1.3% | -3.7% | +0.7% | +3.2% | -4.4% | -2.4% | +9.8% | +15.6% | -8.1% | +8.1% | +27.0% | – | |
| – | +13.7% | -14.9% | -16.5% | +2.3% | -7.2% | -2.0% | +9.9% | +6.7% | -5.1% | +7.8% | +19.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -61.5% | -40.0% | +0.0% | +0.0% | -22.2% | -85.7% | +2,700.0% | +71.4% | +33.3% | +1.6% | -27.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -22.2% | -82.1% | +40.0% | -42.9% | -25.0% | +33.3% | +75.0% | -71.4% | +50.0% | +200.0% | +77.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 4, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.